IGF2 and prostate cancer: Earlier studies have shown that LOI of IGF2 is associated with somatic overgrowth and embryonal tumors and has been linked to more than 20 types of cancer in humans, including Wilms’ tumor and colorectal, lung, breast and prostate cancer (22).